| 查看: 1274 | 回复: 4 | |||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | |||
[交流]
急。求助翻译。质量一般就行，不要机译。谢谢
|
|||
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristicsfor improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. Stearic acid based nanoparticles of carvedilol phosphate were fabricated by solvent emulsification evaporation technique in sodium taurocholate solution prepared in pH 7.2 buffers (I—KH2PO4/NaOH or II—NaH2PO4/Na2HPO4) with 1% polyvinyl alcohol. Nanoparticles were then adsorbed by passing the nanodispersion through a Neusilin US2 (adsorbent) column. Interestingly, scanning electron microscopy revealed round deformed and even collapsed nanoparticles in Buffer-I and discrete spherical to ellipsoidal nanoparticles in Buffer-II which indicates the inability of nanoemulsion to crystallize and form SLN in Buffer-I. The successful formation of SLN in Buffer-II was confirmed by differential scanning calorime try and X-ray diffraction. The retention of SLN from the nanodispersion by adsorption on the adsorbent imparted good flow property and resulted in a marked stability improvement of the formulation in terms of drug retention efficiency and release profile as compared to the simple nanosuspension. In conclusion, the adsorbent technology would be instrumental in imparting additional features to the existing conventional colloidal system for pharmaceutical application which would ease the process of capsule filling at industrial scale, simplify the handling of formulations by patients and can significantly improve the shelf life of the product for a longer period of time as compared to liquid formulations. improve stability. However, the coexistence of high concentration of stabilizing agents (surfactants) along with the lipid nanopartiSolid lipid based colloidal carriers of drugs have attracted considerable attention in the last two decades [1–4]. As they are derived from physiologically compatible lipids, solid lipid nanoparticles (SLN) represent a safe and effective alternative which include additional advantages and are devoid of the potential toxicities of conventional polymeric nanoparticles [5–7]. SLN for oral drug administration have specifically been employed for improving bioavailability by targeting the uptake of the drug by lymphatic system which prevents its hepatic first pass metabolism [8–11]. Despite the perceived therapeutic advantages of SLN, the technology available so far for the fabrication of SLN is restricted to the development of nanodispersion which has not had been so encouraging. In an aqueous nanodispersion, the SLN have a tendency to undergo particle aggregation under accelerated storage conditions due to the gelation phenomenon (an irreversible conversion of low viscosity lipid based nanoparticles dispersion into a viscous gel) due to which the dispersion is usually lyophilized into a dry powder to cles (LNs) in the final product is not desirable because of their toxic effects on the mucosal lining of the GIT. Moreover, the process of lyophilization is critical as rate of freezing governs the structure and properties of the lipid crystals which finally determines its drug retention capacity during storage. Alternatively, filtration of the nanoparticles as a whole is a costly and exhaustive process due to the requirement of sophisticated equipments for retaining particles in nanosize range. Apart from the above, surfactants essentially employed in the production of SLN increase solubility of the poorly soluble/insoluble drug in the external phase. This matter is of serious concern during production and upon long term storage as it results in progressive leaching of drug from the particles to external phase which results in reduced drug loading efficiency. The above issues have been discussed in detail in literature [12].The above discussion indicates that there is a necessity to develop a method which can separate the nanoparticles from the dispersion and immobilize them in order to retain their individual morphological identity upon storage. Harvesting the SLN from the nanodispersion by surface adsorption or retention on a submicron size inert pharmaceutical excipient with good flowability, compressibility and adsorption capacity may be an excellent approach to overcome the above mentioned issues. The prepared “Adsorbed Lipid Nanoparticles” (ALN) would not only maintain the integrity of each adsorbed nanoparticle but also ease its filling into capsules or compression into tablet. To our knowledge, such a unique approach in the development of SLN delivery system has not been reported so far. However, limited studies involving the use of adsorbents to obtain lipid based granules for oral drug delivery have been reported wherein adsorbents were found to enhance the bioavailability of the drug and impart significant flow and compressibility to the final blend [13–15].The drug employed here is carvedilol phosphate, a non-selective-blocker. The drug exhibits poor aqueous solubility and highlipophilicity (log P) which makes it an excellent candidate for SLN encapsulation[16,17]. A study conducted previously in our laboratory using different types and concentration of surfactants at different pH has shown that sodium taurocholate (STC) has both minimum molar solubilization capacity and binding constant for carvedilol phosphate at pH 7.2 [18]. Therefore, the objective of the present work was to develop SLN of carvedilol phosphate using STC as a stabilizing agent and pH 7.2 phosphate buffer as dispersion medium, and improve the physicochemical properties of the nanoparticles by adsorbing them onto Neusilin (magnesium aluminometasilicate), an inert pharmaceutical excipient used as adsorbent. 2. Materials and methods [ Last edited by kaichang on 2011-1-9 at 13:15 ] |
回复此楼» 猜你喜欢
270求调剂
已经有8人回复
-
211本科材料化工求调剂
已经有6人回复
-
求调剂
已经有10人回复
-
求调剂
已经有11人回复
-
272分材料子求调剂
已经有43人回复
-
271求调剂
已经有13人回复
-
283求调剂 086004考英二数二
已经有16人回复
-
085410 273分调剂
已经有4人回复
-
一志愿厦大0856，306求调剂
已经有3人回复
-
304求调剂（085602，过四级，一志愿985）
已经有28人回复
» 抢金币啦！回帖就可以得到:
-
★★热帖★★0860生物与医药调剂考生看过来，河北大学化学与材料科学学院
+2/102
-
★★爆★★河北大学分析化学专业，强势学科，捡漏了，0703化学考生均可填报调剂
+1/89
-
太原科技大学硕士
+1/87
-
香港科技大学(广州) CCUS及吸附分离方向全奖博士生，年津贴18万
+1/84
-
河南农业大学理学院仿生应用化学创新团队招收硕士调剂生
+1/56
-
生物专业调剂生，有4个调剂名额
+1/40
-
太原科技大学光学工程、光电信息工程接受调剂
+1/10
-
河南农业大学理学院招收化学（学硕）和材料与化工（专硕）专业硕士调剂生2名
+1/10
-
济南大学材料科学与工程学院招收硕士调剂生
+1/9
-
浙江农林大学 林业与生物技术学院 生物学(生物化学与分子生物学) 第二轮调剂生招生
+1/9
-
陕西科技大学轻工科学与工程学院刘老师接收08专业研究生调剂
+1/8
-
华北理工大学-化学工程学院招收材料/化学/化工/环境专业硕士
+1/8
-
福建农林大学秦源课题组招收2026年 生物学、生物技术与工程专业研究生若干名
+1/6
-
河南理工大学化学化工学院招收材料、化工类专业调剂研究生
+1/5
-
招收化学/材料调剂同学
+1/4
-
湖南大学白玉罡课题组招收2026年入学博士生（第二批补录）
+1/4
-
西南科技大学国家重点实验室李老师课题组接收材料、化学和化工类研究生调剂
+1/4
-
北京高校副校长团队招收机械类，环境类学硕和专硕
+1/4
-
中国民航大学招收2026年物理学学术硕士20人
+1/3
-
湖南农业大学能源材料创新团队招收2026化学专业研究生（学硕）调剂
+1/2
kaichang(金币+2, 翻译EPI+1):尽管只有一句，不过还是谢谢。有空就全部帮我翻译了吧。 2011-01-09 18:51:36
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristics for improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. 本文的目的是采用能自由流动的吸附剂，来改善作口服剂之用的固体脂质纳米粒的稳定性与物理性能。 |
2楼2011-01-09 17:21:15
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristicsfor improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. Stearic acid based nanoparticles of carvedilol phosphate were fabricated by solvent emulsification evaporation technique in sodium taurocholate solution prepared in pH 7.2 buffers (I—KH2PO4/NaOH or II—NaH2PO4/Na2HPO4) with 1% polyvinyl alcohol. 本文的目的是采用能自由流动的吸附剂，来改善作口服剂之用的固体脂质纳米粒的稳定性与物理性能。基于卡维地洛磷酸盐的硬脂酸是由溶剂乳化蒸发技术制得，该过程是在1%的聚乙烯醇产生的ph值为7.2的缓冲池中制备的牛黄胆酸钠中完成的。 |
3楼2011-01-09 18:51:08
4楼2011-01-10 00:05:25
5楼2011-01-10 01:12:07
